Eclipse Surgical PTMR PMA Application Planned For Fourth Quarter
This article was originally published in The Gray Sheet
Executive Summary
Eclipse Surgical Technologies is planning a fourth-quarter premarket approval application submission to FDA for its minimally invasive percutaneous transmyocardial revascularization (PTMR) holmium laser system for treatment of angina patients not amenable to conventional treatment.